AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimyadd M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aytas Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimyadd M 1mg/500mg Tablet

Diabetam Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetam Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar responses. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Glimyadd M 1mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimyadd M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimyadd M 1mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glimyadd M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimyadd M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimyadd M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Glimyadd M 1mg/500mg Tablet works:

Glimiride/Metformin 1mg/500mg tablets combine the actions of two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimyadd M 1mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimyadd M 1mg/500mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Lactation and Glimyadd M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimyadd M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimyadd M 1mg/500mg tablets. Medical advice is necessary. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimyadd M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typical; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimyadd M 1mg/500mg Tablet :

Should you forget a dose of Glimyadd M 1mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimyadd M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimyadd M 1mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimyadd M 1mg/500mg Tablets may cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but significant adverse reaction linked to metformin use. Consequently, its use is cautioned in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Glimyadd M 1mg/500mg Tablets and prompt medical attention.
Glimyadd M 1mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glimyadd M 1mg/500mg Tablets may cause common adverse reactions including hypoglycemia, taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Prolonged Glimyadd M 1mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency due to impaired gastric absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Indeed, Glimyadd M 1mg/500mg Tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimyadd M 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption may exacerbate hypoglycemia by further reducing blood sugar, and raises the risk of lactic acidosis.
Glimyadd M 1mg/500mg Tabl...
57
MRP 69
17% off